Literature DB >> 7856765

Major gene for percent of oxygen saturation of arterial hemoglobin in Tibetan highlanders.

C M Beall1, J Blangero, S Williams-Blangero, M C Goldstein.   

Abstract

This report employs a statistical genetic approach to analyze quantitative oxygen transport variables in a high-altitude (4,850-5,450 m) native Tibetan population and demonstrates the presence of a major gene influencing % O2 saturation of arterial hemoglobin. This result suggests the hypothesis that individuals with the dominant allele for higher % O2 saturation have a selective advantage at high altitude. Studies of the biologically distinctive Himalayan and Andean populations have greatly influenced thinking about ongoing human evolution and adaptation; this is the first statistical evidence for a major gene enhancing oxygen transport in a high-altitude native population.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7856765     DOI: 10.1002/ajpa.1330950303

Source DB:  PubMed          Journal:  Am J Phys Anthropol        ISSN: 0002-9483            Impact factor:   2.868


  20 in total

1.  Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlanders.

Authors:  Cynthia M Beall; Gianpiero L Cavalleri; Libin Deng; Robert C Elston; Yang Gao; Jo Knight; Chaohua Li; Jiang Chuan Li; Yu Liang; Mark McCormack; Hugh E Montgomery; Hao Pan; Peter A Robbins; Kevin V Shianna; Siu Cheung Tam; Ngodrop Tsering; Krishna R Veeramah; Wei Wang; Puchung Wangdui; Michael E Weale; Yaomin Xu; Zhe Xu; Ling Yang; M Justin Zaman; Changqing Zeng; Li Zhang; Xianglong Zhang; Pingcuo Zhaxi; Yong Tang Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 2.  Drugs for increasing oxygen and their potential use in doping: a review.

Authors:  Aurelie Gaudard; Emmanuelle Varlet-Marie; Francoise Bressolle; Michel Audran
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  Altitude sickness: hyperventilatory capacity may predict altitude sickness.

Authors:  Maximilian Ledochowski; Dietmar Fuchs
Journal:  BMJ       Date:  2003-07-12

Review 4.  Metabolic changes through hypoxia in humans and in yeast as a comparable cell model.

Authors:  Nikolaus C Netzer; Michael Breitenbach
Journal:  Sleep Breath       Date:  2010-06-10       Impact factor: 2.816

5.  Lessons in hypoxic adaptation from high-altitude populations.

Authors:  Kingman P Strohl
Journal:  Sleep Breath       Date:  2008-05       Impact factor: 2.816

6.  Developmental Effects Determine Submaximal Arterial Oxygen Saturation in Peruvian Quechua.

Authors:  Melisa Kiyamu; Fabiola León-Velarde; María Rivera-Chira; Gianpietro Elías; Tom D Brutsaert
Journal:  High Alt Med Biol       Date:  2015-05-15       Impact factor: 1.981

7.  An Ethiopian pattern of human adaptation to high-altitude hypoxia.

Authors:  Cynthia M Beall; Michael J Decker; Gary M Brittenham; Irving Kushner; Amha Gebremedhin; Kingman P Strohl
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-05       Impact factor: 11.205

8.  Identifying signatures of natural selection in Tibetan and Andean populations using dense genome scan data.

Authors:  Abigail Bigham; Marc Bauchet; Dalila Pinto; Xianyun Mao; Joshua M Akey; Rui Mei; Stephen W Scherer; Colleen G Julian; Megan J Wilson; David López Herráez; Tom Brutsaert; Esteban J Parra; Lorna G Moore; Mark D Shriver
Journal:  PLoS Genet       Date:  2010-09-09       Impact factor: 5.917

9.  Higher offspring survival among Tibetan women with high oxygen saturation genotypes residing at 4,000 m.

Authors:  Cynthia M Beall; Kijoung Song; Robert C Elston; Melvyn C Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-07       Impact factor: 11.205

10.  Identifying positive selection candidate loci for high-altitude adaptation in Andean populations.

Authors:  Abigail W Bigham; Xianyun Mao; Rui Mei; Tom Brutsaert; Megan J Wilson; Colleen Glyde Julian; Esteban J Parra; Joshua M Akey; Lorna G Moore; Mark D Shriver
Journal:  Hum Genomics       Date:  2009-12       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.